Gross Profit Summary of Marksans Pharma Limited

Marksans Pharma Limited's latest annual gross profit in 2023 was 7.71 Billion INR , down -16.9% from previous year.
Marksans Pharma Limited's latest quarterly gross profit in 2024 Q1 was 2.27 Billion INR , up 20.34% from previous quarter.
Marksans Pharma Limited reported a annual gross profit of 9.28 Billion INR in annual gross profit 2022, up 21.61% from previous year.
Marksans Pharma Limited reported a annual gross profit of 7.63 Billion INR in annual gross profit 2021, up 1.8% from previous year.
Marksans Pharma Limited reported a quarterly gross profit of 1.89 Billion INR for 2023 Q4, down -39.55% from previous quarter.
Marksans Pharma Limited reported a quarterly gross profit of 2.78 Billion INR for 2023 Q2, up 8.26% from previous quarter.

Annual Gross Profit Chart of Marksans Pharma Limited (2023 - 2004)

Historical Annual Gross Profit of Marksans Pharma Limited (2023 - 2004)

Year	Gross Profit	Gross Profit Growth
2023	7.71 Billion INR	-16.9%
2022	9.28 Billion INR	21.61%
2021	7.63 Billion INR	1.8%
2020	7.49 Billion INR	39.35%
2019	5.38 Billion INR	14.52%
2018	4.69 Billion INR	32.02%
2017	3.55 Billion INR	22.46%
2016	2.9 Billion INR	-21.68%
2015	3.71 Billion INR	5.64%
2014	3.51 Billion INR	34.03%
2013	2.62 Billion INR	41.23%
2012	1.85 Billion INR	30.1%
2011	1.42 Billion INR	40.12%
2010	1.01 Billion INR	56.12%
2009	651.94 Million INR	-11.26%
2008	734.69 Million INR	15.23%
2007	637.59 Million INR	40.89%
2006	452.53 Million INR	-33.7%
2005	682.53 Million INR	6.31%
2004	642.01 Million INR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	2.27 Billion INR	20.34%
2023 Q4	1.89 Billion INR	-39.55%
2023 Q2	2.78 Billion INR	8.26%
2023 Q3	3.13 Billion INR	12.49%
2023 FY	7.71 Billion INR	-16.9%
2023 Q1	2.57 Billion INR	7.37%
2022 Q4	2.39 Billion INR	-0.3%
2022 Q3	2.4 Billion INR	4.79%
2022 FY	9.28 Billion INR	21.61%
2022 Q1	2.18 Billion INR	33.08%
2022 Q2	2.29 Billion INR	4.75%
2021 Q4	1.64 Billion INR	-15.68%
2021 Q2	1.85 Billion INR	-0.45%
2021 Q3	1.95 Billion INR	5.0%
2021 FY	7.63 Billion INR	1.8%
2021 Q1	1.86 Billion INR	25.71%
2020 FY	7.49 Billion INR	39.35%
2020 Q1	1.91 Billion INR	20.34%
2020 Q2	1.92 Billion INR	0.62%
2020 Q3	2.16 Billion INR	12.52%
2020 Q4	1.48 Billion INR	-31.55%
2019 FY	5.38 Billion INR	14.52%
2019 Q1	1.2 Billion INR	30.66%
2019 Q2	1.23 Billion INR	2.48%
2019 Q3	1.47 Billion INR	19.2%
2019 Q4	1.59 Billion INR	7.93%
2018 Q2	1.37 Billion INR	15.54%
2018 Q4	924.22 Million INR	-23.09%
2018 FY	4.69 Billion INR	32.02%
2018 Q1	1.19 Billion INR	100.42%
2018 Q3	1.2 Billion INR	-12.85%
2017 Q2	976.27 Million INR	3.06%
2017 FY	3.55 Billion INR	22.46%
2017 Q4	595.46 Million INR	-42.73%
2017 Q3	1.03 Billion INR	6.51%
2017 Q1	947.31 Million INR	79.2%
2016 Q1	769.64 Million INR	17.57%
2016 FY	2.9 Billion INR	-21.68%
2016 Q3	949.66 Million INR	34.99%
2016 Q4	528.63 Million INR	-44.33%
2016 Q2	703.52 Million INR	-8.59%
2015 FY	3.71 Billion INR	5.64%
2015 Q2	1.19 Billion INR	28.71%
2015 Q1	926.29 Million INR	15.47%
2015 Q3	1.06 Billion INR	-10.82%
2015 Q4	654.62 Million INR	-38.43%
2014 Q4	802.16 Million INR	-16.35%
2014 Q2	922.15 Million INR	11.2%
2014 FY	3.51 Billion INR	34.03%
2014 Q1	829.29 Million INR	51.61%
2014 Q3	958.91 Million INR	3.99%
2013 Q2	691.07 Million INR	11.24%
2013 FY	2.62 Billion INR	41.23%
2013 Q4	546.98 Million INR	-25.44%
2013 Q3	733.66 Million INR	6.16%
2013 Q1	621.23 Million INR	14.48%
2012 Q3	455.12 Million INR	-0.16%
2012 Q2	455.85 Million INR	12.76%
2012 FY	1.85 Billion INR	30.1%
2012 Q1	404.28 Million INR	0.0%
2012 Q4	542.64 Million INR	19.23%
2011 FY	1.42 Billion INR	40.12%
2010 FY	1.01 Billion INR	56.12%
2009 FY	651.94 Million INR	-11.26%
2008 FY	734.69 Million INR	15.23%
2007 FY	637.59 Million INR	40.89%
2006 FY	452.53 Million INR	-33.7%
2005 FY	682.53 Million INR	6.31%
2004 FY	642.01 Million INR	0.0%

Peer Gross Profit Comparison of Marksans Pharma Limited

Name	Gross Profit	Gross Profit Difference
Abbott India Limited	26.16 Billion INR	70.519%
Cipla Limited	161.81 Billion INR	95.233%
Gland Pharma Limited	16.37 Billion INR	52.884%
GlaxoSmithKline Pharmaceuticals Limited	12.82 Billion INR	39.831%
Kopran Limited	1.47 Billion INR	-423.032%
NGL Fine-Chem Limited	1.23 Billion INR	-525.895%
Pfizer Limited	9.9 Billion INR	22.124%
Sanofi India Limited	15.93 Billion INR	51.598%
SMS Pharmaceuticals Limited	2.08 Billion INR	-269.523%

Global Stocks Search

Marksans Pharma Limited (MARKSANS.BO)

Gross Profit Summary of Marksans Pharma Limited

Annual Gross Profit Chart of Marksans Pharma Limited (2023 - 2004)

Historical Annual Gross Profit of Marksans Pharma Limited (2023 - 2004)

Peer Gross Profit Comparison of Marksans Pharma Limited